Handbook of Parkinson's Disease

Rajesh Pahwa MD is a clinician and Laverne and Joyce Rider Professor of Neurology and Director of the Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center. Kelly E Lyons PhD is Director of Research and Education at the Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center.

"…This new edition of the Handbook of Parkinson's Disease covers all new aspects of the condition and fulfils all the needs of an authoritative and recent update. The editors have put together an excellent group of authors. Each of them is a well-known specialist in their field and the chapters are scholarly and easy to read."—Günther Deuschl, Professor of Neurology, Chairman of the Department of Neurology, Christian-Albrechts-University Kiel, Universiätsklinikum Schleswig-Holstein, Germany (from the Foreword)"a thorough and wide ranging overview of the differential diagnosis, investigation, management and pathophysiology of Parkinson’s disease (PD). … anyone who is either involved in the medical management of patients with PD, or researches the condition, would benefit from having access to this book." Highly Commended."—2014 BMA Medical Book AwardsPraise for the Previous Edition"…valuable to the neurologist or psychiatrist who treats Parkinson's patients or to anyone who enjoys the pure intellectual pleasure of watching scientific progress unfold in the understanding of Parkinson's disease."—Journal of Neuropsychiatry and Clinical Neurosciences"...covers all aspects of Parkinson's disease and is the best general text on the topic."—Journal of Neurology, Neurosurgery and Psychiatry

• Early Iconography of Parkinson’s Disease. Epidemiology. Differential Diagnosis. Pathophysiology and Clinical Assessment. Premotor Symptoms. Autonomic Dysfunction and Management. Sleep Dysfunction. Neuropsychological Aspects. Management of Anxiety and Depression. Management of Psychosis and Dementia. Neuroimaging. Neuropathology. Neurophysiology and Neurocircuitry. Animal Models. Genetics. Environmental Risk Factors. Disease Modification. Amantadine and Anticholinergics. Levodopa. Dopamine Agonists. MAO inhibitors. COMT Inhibitors. Investigational Pharmacological Treatments. Deep Brain Stimulation. Investigational Surgical Therapies. Physical and Occupational Therapy. Voice, Speech and Swallowing Disorders. Alternative Therapies.